In 2024, Rohto Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Waste Generated | 2,291a | 2,567a | 2,456a | |
Total Waste Recovered | 1,433a | 1,866a | 1,512a | |
Total Hazardous Waste Generated | N/A | N/A | N/A | |
Non-Hazardous Waste Disposed | N/A | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, Rohto Pharmaceutical generated a total of 2,291metric tonnes of waste.a
Of this amount, 62.55% of Rohto Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 0.09% was disposed of through landfilling, incineration, or combustion.The remaining 37.36% was either treated using unspecified methods or not clearly categorized.a
In 2024, Rohto Pharmaceutical reported a total waste generation of 2,291 metric tonnes, of which 62.55% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Rohto Pharmaceutical is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2020, Rohto Pharmaceutical's total waste generation decreased by 18.24%, including a further 10.75% drop in 2024, highlighting a consistent and deliberate reduction in waste production over time.a
Over the same period, Rohto Pharmaceutical's waste recovery rate increased by 29.15%, but declined by 13.95% in 2024, potentially signaling volatility in waste treatment processes or shifting priorities in waste management.a
Overall, Rohto Pharmaceutical’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.